Preclinical Neonatal Rat Studies of Heparin-Binding EGF-Like Growth Factor in Protection of the Intestines From Necrotizing Enterocolitis
Open Access
- 1 April 2009
- journal article
- research article
- Published by Springer Nature in Pediatric Research
- Vol. 65 (4) , 437-442
- https://doi.org/10.1203/pdr.0b013e3181994fa0
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Necrotizing enterocolitis: A multifactorial disease with no cureWorld Journal of Gastroenterology, 2008
- Tissue distribution and plasma clearance of heparin-binding EGF-like growth factor (HB-EGF) in adult and newborn ratsPeptides, 2006
- Heparin-binding epidermal growth factor–like growth factor decreases the incidence of necrotizing enterocolitis in neonatal ratsJournal of Pediatric Surgery, 2006
- Timing, route, and dose of administration of heparin-binding epidermal growth factor–like growth factor in protection against intestinal ischemia-reperfusion injuryJournal of Pediatric Surgery, 2005
- A pilot study of the use of epidermal growth factor in pediatric short bowel syndromeJournal of Pediatric Surgery, 2005
- ErbB4 and Its Isoforms Selective Regulation of Growth Factor Responses by Naturally Occurring Receptor VariantsTrends in Cardiovascular Medicine, 2000
- A Multicenter, Randomized, Double-Blind Clinical Trial Examining the Effect of Oral Human Recombinant Epidermal Growth Factor on the Healing of Duodenal UlcersScandinavian Journal of Gastroenterology, 2000
- Role of Asphyxia and Feeding in a Neonatal Rat Model of Necrotizing EnterocolitisPediatric Pathology, 1994
- Necrotizing EnterocolitisNew England Journal of Medicine, 1984
- An experimental study of acute neonatal enterocolitis—the importance of breast milkJournal of Pediatric Surgery, 1974